CIK 0001385818
- Non-accelerated filer
- Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 470883144
- Phone
- +1 720-437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 4 Grant or award Director acquired 6,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,500 shares (grant or award)
- 4 Grant or award Director acquired 1,500 shares (grant or award)
- 4 Grant or award Director acquired 1,500 shares (grant or award)
- 4 Grant or award Director acquired 1,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Commerical Officer acquired 208 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Commerical Officer bought 12,000 shares at $1.87 ($22,428)
- 4 Exercise or conversion Chief Commerical Officer acquired 833 shares (option exercise)
- 4 Open-market buy Chief Executive Officer bought 14,000 shares at $1.86 ($26,079)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 6,500 shares (grant or award)
- 4 Returned to the company Director returned 187,804 shares (to the company)
- 4 Returned to the company Director returned 40,000 shares (to the company)
- 4 Returned to the company Chief Executive Officer returned 80,000 shares (to the company)
Page 3 of 10 · 187 filings